INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 3 filers reported holding INTRA CELLULAR THERAPIES INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,393,977 | -17.7% | 65,156 | 0.0% | 0.73% | -15.1% |
| Q2 2023 | $4,125,678 | +16.3% | 65,156 | -0.5% | 0.86% | +7.6% |
| Q1 2023 | $3,546,067 | +3.4% | 65,486 | +1.0% | 0.80% | -0.6% |
| Q4 2022 | $3,430,063 | +13.7% | 64,816 | -0.1% | 0.80% | +4.7% |
| Q3 2022 | $3,018,000 | -18.5% | 64,853 | -0.0% | 0.77% | -13.6% |
| Q2 2022 | $3,702,000 | -6.7% | 64,858 | 0.0% | 0.89% | +10.1% |
| Q1 2022 | $3,969,000 | – | 64,858 | – | 0.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 640,000 | $25,626,000 | 6.33% |
| Redmile Group, LLC | 1,322,592 | $52,957,000 | 4.01% |
| SENZAR ASSET MANAGEMENT, LLC | 556,224 | $22,271,209,000 | 3.24% |
| RA Capital Management | 314,349 | $12,587,000 | 1.81% |
| WALL STREET ASSOCIATES | 205,657 | $8,235,000 | 1.58% |
| Parametrica Management Ltd | 5,400 | $216,000 | 1.36% |
| Rhenman & Partners Asset Management AB | 165,000 | $6,607,000 | 1.05% |
| EAM Investors, LLC | 95,168 | $3,811,000 | 0.60% |
| Rock Springs Capital Management LP | 180,000 | $7,207,000 | 0.58% |
| WASATCH ADVISORS LP | 1,085,973 | $43,482,000 | 0.58% |